CD8+ T CELLS THAT ALSO EXPRESS PD-1 AND/OR TIM-3 FOR THE TREATMENT OF CANCER Read more about CD8+ T CELLS THAT ALSO EXPRESS PD-1 AND/OR TIM-3 FOR THE TREATMENT OF CANCER Hong Kong42020016957.1Filed on 2020-09-28
HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS Read more about HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS Hong Kong62020019700.7Filed on 2020-11-09
METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION Read more about METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION Hong Kong62020021274.9Filed on 2020-11-30
METHODS OF ISOLATING NEOANTIGEN-SPECIFIC T CELL RECEPTOR SEQUENCES Read more about METHODS OF ISOLATING NEOANTIGEN-SPECIFIC T CELL RECEPTOR SEQUENCES Hong Kong62020013025.5Filed on 2020-07-31
METHODS OF ISOLATING T CELL POPULATIONS Read more about METHODS OF ISOLATING T CELL POPULATIONS Patent Cooperation TreatyPCT/US2020/051548Filed on 2020-09-18
T CELL RECEPTORS SPECIFIC FOR MUTATED KIRSTEN RAT SARCOMA VIRAL ONCOGENE HOMOLOG Read more about T CELL RECEPTORS SPECIFIC FOR MUTATED KIRSTEN RAT SARCOMA VIRAL ONCOGENE HOMOLOG Saudi Arabia520420365Filed on 2020-10-15
T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage Read more about T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage European Patent20192082.4Filed on 2020-08-21
Anti-Human Papillomavirus 16 E7 T Cell Receptors Read more about Anti-Human Papillomavirus 16 E7 T Cell Receptors Saudi Arabia520412601Filed on 2020-08-06
Methods For Pre-conditioning Patients For Cell Therapy Read more about Methods For Pre-conditioning Patients For Cell Therapy NigeriaNG/PT/C/2018/3399Filed on 2018-11-20
Chimeric Antigen Receptors Containing Glypican 2 Binding Domains Read more about Chimeric Antigen Receptors Containing Glypican 2 Binding Domains Patent Cooperation TreatyPCT/US2020/042469Filed on 2020-07-17